Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Researchers confirmed this through knockout studies in mice, where animals lacking beta-3 adrenergic receptors showed zero response to AOD 9604, proving the peptide works specifically through this receptor pathway in adipose tissue
B12 injections are typically administered either intramuscularly (IM) or subcutaneously, with common sites being the deltoid, thigh, or gluteal muscles
Body fat measurement through calipers, bioelectrical impedance, or DEXA scanning provides the most direct fat loss data
While AOD 9604 is not a muscle-building peptide, its selective fat-targeting mechanism means more of the weight lost comes from fat rather than lean tissue
Cycle breaks become mandatory if you have been on protocol for 12+ weeks continuously or if response has dropped significantly despite dose adjustment
Reported side effects are generally mild and may include injection site irritation, headache, or transient fatigue
